Factors associated with enrollment in cancer genetics research

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 7, 2006, Pages 1355-1359

  Ford, Beth M ^a   Evans, James S ^c   Stoffel, Elena M ^a,b,d   Balmaña, Judith ^a,e   Regan, Meredith M ^a   Syngal, Sapna ^a,b,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MSH6;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER EPIDEMIOLOGY; CANCER GENETICS; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; DIGESTIVE SYSTEM CANCER; DNA DETERMINATION; ETHNOLOGY; FAMILY HISTORY; FEMALE; HUMAN; INFORMED CONSENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; QUESTIONNAIRE;

AGED; BIOMEDICAL RESEARCH; CHILD; CLINICAL TRIALS; COLORECTAL NEOPLASMS; FEMALE; GENETIC SERVICES; HUMANS; MALE; MINORITY GROUPS; PATIENT SELECTION; POPULATION GROUPS; RESEARCH DESIGN; RESEARCH PERSONNEL;

EID: 33746412297     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0816     Document Type: Article

References (34)

1. Wright JR, Whelan TJ, Schiff S, et al. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 2004;22:4312-8.
2. Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 2000;10:S22-34.
3. Madsen SM, Mirza MR, Holm S, Hilsted KL, Kampmann K, Riis P. Attitudes towards clinical research amongst participants and nonparticipants. J Intern Med 2002;251:156-68.
4. Grunfeld E, Zitzelsberger L, Coristine M, Aspelund F. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer 2002;95:1577-83.
5. Brawley OW. The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol 2004;22:2039-40.
6. Martel CL, Li Y, Beckett L, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J 2004;10:294-300.
7. Lara PN, Jr., Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-33.
8. Wright JR, Crooks D, Ellis PM, Mings D, Whelan TJ. Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate. Cancer 2002;95:1584-91.
9. Cassileth BR. Clinical trials: time for action. J Clin Oncol 2003;21:765-6.
10. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14:537-46.
11. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-17.
12. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS. Under-representation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061-7.
13. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21:1383-9.
14. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 2001;19:3554-61.
15. Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999;9:188-95.
16. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-6.
17. Corbie-Smith G, Thomas SB, St George DM. Distrust, race, and research. Arch Intern Med 2002;162:2458-63.
18. McQuillan GM, Porter KS, Agelli M, Kington R. Consent for genetic research in a general population: the NHANES experience. Genet Med 2003;5:35-42.
19. Richards MP, Ponder M, Pharoah P, Everest S, Mackay J. Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. J Med Ethics 2003;29:93-6.
20. Chen DT, Rosenstein DL, Muthappan P, et al. Research with stored biological samples: what do research participants want? Arch Intern Med 2005;165:652-5.
21. Deschenes M, Cardinal G, Knoppers BM, Glass KC. Human genetic research, DNA banking and consent: a question of "form"? Clin Genet 2001;59:221-39.
22. Knoppers BM, Laberge CM. Research and stored tissues. Persons as sources, samples as persons? JAMA 1995;274:1806-7.
23. Wang SS, Fridinger F, Sheedy KM, Khoury MJ. Public attitudes regarding the donation and storage of blood specimens for genetic research. Community Genet 2001;4:18-26.
24. Hughes C, Peterson SK, Ramirez A, et al. Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 2004;13:1146-55.
25. Moorman PG, Skinner CS, Evans JP, et al. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 2004;13:1349-54.
26. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
27. Klabunde CN, Springer BC, Butler B, White MS, Atkins J. Factors influencing enrollment in clinical trials for cancer treatment. South Med J 1999;92:1189-93.
28. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21:830-5.
29. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001;358:1772-7.
30. Tattersall M. Cancer clinical trial recruitment. Cancer 2002;95:1397-400.
31. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA 2004;292:1593-601.
32. Gotay CC. Perceptions of informed consent by participants in a prostate cancer prevention study. Cancer Epidemiol Biomarkers Prev 2001;10:1097-9.
33. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003;97:1499-506.
34. Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health 1997;2:31-45.